MedPath
NMPA Approval

Isatuximab Injection

国药准字SJ20250001

January 8, 2025

Drug Information

艾沙妥昔单抗注射液

赛可益

注射剂

100mg(5ml)/瓶

生物制品

January 8, 2025

January 7, 2030

Company Information

Applicant Company

82 avenue Raspail, 94250 Gentilly, France

Manufacturing Company

Industriepark Hoechst Brueningstrasse 50 65926 Frankfurt am Main, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

艾沙妥昔单抗注射液 - NMPA 批准文号 | MedPath